Skip to main content
GoodwinGoodwin
Insight
March 2, 2023

A Recap of Resilience: Goodwin’s Life Sciences Practice

Last year, our Life Sciences practice continued helping clients thrive in the face of changing tides.

View PDF

In 2022, life sciences companies witnessed a sea of changes that brought both new challenges and opportunities. Goodwin helped, and continues to help, clients across the life sciences ecosystem navigate these stormy waters as they look for strategies to enhance research and development, optimize value from licensing, enter M&A and other transactions, and secure capital for growth.

This recap highlights the resilience of these industry-leading companies and the agility of our full-service, integrated global practice. We are continually inspired by our clients and look forward to our ongoing partnerships as we embrace 2023 and the evolving life sciences legal landscape.

By The Numbers

*Representation of both issuers and underwriters
170+
Financing (VC) Transactions for Over $14.5 Billion
5+
IPO Transactions for Over $650 Million*
35+
M&A Transactions for Over $15.5 Billion
55+
Follow-On Offerings for Over $7.2 Billion*
60+
Collaboration Transactions for Over $4.5 Billion

Our Global Recognition

Chambers USA
Ranked Goodwin Band 1 in the Nationwide: Life Sciences category
Chambers UK
Goodwin in the UK-wide Life Sciences: Transactional category
Best Law Firms U.S. News & World Report Best Lawyers
Seven-time winner of Biotech Law Firm of the Year and National Tier 1 ranking in 23 areas
LMG Life Sciences

U.S. Life Cycle Firm of the Year for the 11th consecutive year, one of only eight firms to receive this distinction

FDA Litigation and Enforcement Firm of the Year

LMG Life Sciences

Venture Capital Attorney of the Year

Regulatory Attorney of the Year: FDA Pharmaceutical

IAM 1000
Named Goodwin a leader in patent law
Chambers Global
Goodwin’s UK and US teams in the Life Sciences & Pharmaceutical Sector (International & Cross-Border) category
Refinitiv
Named Goodwin #1 firm for Global M&A in 2022

Notable Deals

Learn More

Goodwin’s fully integrated Life Sciences practice helps clients navigate the industry’s rapidly evolving demands by serving as a “one-stop-shop” service, seamlessly advising through all stages of the corporate lifecycle and guiding our clients’ strategic and business goals.

We are proud to have a dedicated team of life sciences lawyers located in the major innovation hubs across the United States, Europe and Asia, giving our team the unique ability to advise clients when and where our services are needed.

Contacts

Related Content

See More